|
| 37984416 | Hemodynamics and urinary excretion of kidney-injury biomarkers in pediatric kidney transplantation. | Pediatr Transplant | 2024 |
| 35940121 | Ex vivo and in vitro Monocyte Responses Do Not Reflect in vivo Immune Responses and Tolerance. | J Innate Immun | 2023 |
| 38025210 | Assessing GFR With Proenkephalin. | Kidney Int Rep | 2023 |
| 37760610 | Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study. | Cancers (Basel) | 2023 |
| 37759239 | Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk. | Crit Care | 2023 |
| 37909366 | Mediators, consequences and therapeutic considerations in patients with acute kidney injury. | Curr Opin Crit Care | 2023 |
| 37559053 | Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19. | Respir Res | 2023 |
| 37482013 | Associations of dipeptidyl-peptidase 3 with short-term outcome in a mixed admission ICU-cohort. | J Crit Care | 2023 |
| 37843573 | Size does matter. Sustainable choice of intravenous bags. | Intensive Care Med | 2023 |
| 37823871 | [Scepticism about a Chinese herbal mixture for sepsis]. | Ned Tijdschr Geneeskd | 2023 |
| 37762760 | The Impact of Non-Pharmacological Interventions on Delirium in Neurological Intensive Care Unit Patients: A Single-Center Interrupted Time Series Trial. | J Clin Med | 2023 |
| 37638784 | The Obesity Paradox in Patients in Need of Extracorporeal Membrane Oxygenation. | Am J Respir Crit Care Med | 2023 |
| 37291433 | Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells. | Nat Biomed Eng | 2023 |
| 37348752 | The gut microbiota composition has no predictive value for the endotoxin-induced immune response or development of endotoxin tolerance in humans invivo. | Microbes Infect | 2023 |
| 36945034 | CytoSorb hemoperfusion markedly attenuates circulating cytokine concentrations during systemic inflammation in humans in vivo. | Crit Care | 2023 |
| 37343422 | Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections. | J Crit Care | 2023 |
| 37012016 | Study protocol of a randomised, double-blind, placebo-controlled, two-arm parallel-group, multi-centre phase 3 pivotal trial to investigate the efficacy and safety of recombinant human alkaline phosphatase for treatment of patients with sepsis-associated acute kidney injury. | BMJ Open | 2023 |
| 37401137 | Sepsis-associated acute kidney injury-treatment standard. | Nephrol Dial Transplant | 2023 |
| 37333948 | Modulation of Pain Sensitivity by a Hyperventilatory Breathing Exercise and Cold Exposure Training. | J Pain Res | 2023 |
| 37002646 | Evidence-based rationale for low dose nivolumab in critically ill patients with sepsis-induced immunosuppression. | Clin Transl Sci | 2023 |
| 37430375 | Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury. | Crit Care | 2023 |
| 37261364 | Atazanavir-induced unconjugated hyperbilirubinemia prevents vascular hyporeactivity during experimental human endotoxemia. | Front Immunol | 2023 |
| 36621395 | Relationships Between Systemic Inflammation, Intestinal Damage and Postoperative Organ Dysfunction in Adults Undergoing Low-Risk Cardiac Surgery. | Heart Lung Circ | 2023 |
| 36426776 | Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands. | Clin Obes | 2023 |
| 36797757 | Complement activation in severely ill patients with sepsis: no relationship with inflammation and disease severity. | Crit Care | 2023 |
| 36762902 | Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study. | Crit Care Med | 2023 |
| 36455260 | THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS. | Shock | 2023 |
| 36823168 | Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. | Nat Rev Nephrol | 2023 |
| 36822159 | The impact of ADRB2 polymorphisms on immune responses and norepinephrine-induced immunosuppression. | J Leukoc Biol | 2023 |
| 36628268 | Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study. | ERJ Open Res | 2023 |
| 34374504 | Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. | Crit Care Med | 2022 |
| 35675822 | Mature neutrophils and a NF-κB-to-IFN transition determine the unifying disease recovery dynamics in COVID-19. | Cell Rep Med | 2022 |
| 35377133 | An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients. | Clin Pharmacokinet | 2022 |
| 35534059 | Personalised immunotherapy in sepsis: a scoping review protocol. | BMJ Open | 2022 |
| 35696647 | Long-Term Impairments Are Most Pronounced in Critically Ill Patients with COVID-19 with Severe Obesity. | Am J Respir Crit Care Med | 2022 |
| 36405747 | Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19. | Front Immunol | 2022 |
| 36600424 | ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol. | BMJ Open | 2022 |
| 36530868 | Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: <i>Post-hoc</i> analyses of the phase II adrenomedullin and outcome in septic shock 2 trial. | Front Med (Lausanne) | 2022 |
| 35872501 | Hypoxemia in the presence or absence of systemic inflammation does not increase blood lactate levels in healthy volunteers. | J Crit Care | 2022 |
| 36210384 | Personalized medicine in COVID-19. | Intensive Care Med | 2022 |
| 35999470 | New drugs for acute kidney injury. | Intensive Care Med | 2022 |
| 36137351 | End of life decisions in immunocompromised patients with acute respiratory failure. | J Crit Care | 2022 |
| 35963275 | Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults. | Lancet Infect Dis | 2022 |
| 35953772 | The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults. | BMC Infect Dis | 2022 |
| 36324738 | Commentary: Plasma angiotensin II is increased in critical coronavirus disease 2019. | Front Cardiovasc Med | 2022 |
| 36159208 | Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19. | Brain Behav Immun Health | 2022 |
| 35947361 | Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients. | Clin Pharmacokinet | 2022 |
| 35945618 | Clinical sepsis phenotypes in critically ill COVID-19 patients. | Crit Care | 2022 |
| 36316692 | Proenkephalin A 119-159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial. | Crit Care | 2022 |
| 35102040 | The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study. | Eur J Anaesthesiol | 2022 |